Back
Compagnie Financiere Richemont SA Vs. NovoCure Industry Stock Comparison
Sell
37
CFRUY
Compagnie Financiere Richemont SA
Last Price:
14.41
Seasonality Move:
6.19%
Buy
82
NVCR
NovoCure
Last Price:
30.52
Seasonality Move:
2.04%
Sell
37
Compagnie Financiere Richemont SA (CFRUY)
is a Sell
Is Compagnie Financiere Richemont SA a Buy, Sell or Hold?
- The current Compagnie Financiere Richemont SA [CFRUY] share price is $14.41. The Score for CFRUY is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- CFRUY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
82
NovoCure (NVCR)
is a Buy
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $30.51. The Score for NVCR is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
- NVCR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
CFRUY Stock Price Chart
What is Compagnie Financiere Richemont SA's stock price today?
-
The Compagnie Financiere Richemont SA share price today is $14.41
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CFRUY is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVCR Stock Price Chart
CFRUY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.11 | Sell |
Relative Strength Index (14 RSI): | 59.38 | Buy |
Chaikin Money Flow: | 1451557 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.38 - 14.4) | Buy |
Bollinger Bands (100): | (13.91 - 15.45) | Sell |
NVCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.24 | Buy |
Relative Strength Index (14 RSI): | 84.56 | Buy |
Chaikin Money Flow: | -690353 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.69 - 22.01) | Buy |
Bollinger Bands (100): | (15.44 - 20.28) | Buy |
CFRUY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.75 | Buy |
20-day SMA: | 13.72 | Buy |
50-day SMA: | 14.42 | Sell |
200-day SMA: | 15.02 | Sell |
8-day EMA: | 13.91 | Buy |
20-day EMA: | 13.88 | Buy |
50-day EMA: | 14.22 | Buy |
200-day EMA: | 14.65 | Sell |
NVCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.45 | Buy |
20-day SMA: | 18.85 | Buy |
50-day SMA: | 17.12 | Buy |
200-day SMA: | 17.34 | Buy |
8-day EMA: | 23.1 | Buy |
20-day EMA: | 19.92 | Buy |
50-day EMA: | 18.23 | Buy |
200-day EMA: | 19.07 | Buy |
Compagnie Financiere Richemont SA Earnings Growth & CFRUY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.01 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.32 per share.
Compagnie Financiere Richemont SA Technical Analysis
Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovoCure Technical Analysis
Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |